Top compounds associated with response to ZWINT


Feature Type Standardized
Nominal ANOVA
mRNA Bexarotene GDSC1000 pan-cancer AAC -0.037 0.3
mRNA PDMP CTRPv2 pan-cancer AAC 0.039 0.3
mRNA itraconazole CTRPv2 pan-cancer AAC -0.039 0.3
mRNA PIK-93 GDSC1000 pan-cancer AAC 0.029 0.3
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.035 0.3
mRNA BRD-K49290616 CTRPv2 pan-cancer AAC -0.074 0.3
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.036 0.3
mRNA Methotrexate FIMM pan-cancer AAC 0.18 0.3
mRNA Doxorubicin GDSC1000 pan-cancer AAC -0.036 0.3
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.035 0.3
Download CSV